{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T21:10:14Z","timestamp":1794258614731,"version":"4.9.0"},"reference-count":175,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"vor","delay-in-days":102,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ID-2021-8630"],"award-info":[{"award-number":["ID-2021-8630"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["ANRF\/PAIR\/2025\/000029\/PAIR"],"award-info":[{"award-number":["ANRF\/PAIR\/2025\/000029\/PAIR"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018761","name":"Indo-German Science and Technology Centre","doi-asserted-by":"publisher","award":["IGSTC\/PECFAR\/Call 2022\/USAK\/36\/2022-23"],"award-info":[{"award-number":["IGSTC\/PECFAR\/Call 2022\/USAK\/36\/2022-23"]}],"id":[{"id":"10.13039\/501100018761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018761","name":"Indo-German Science and Technology Centre","doi-asserted-by":"publisher","award":["PHD-2023-10682"],"award-info":[{"award-number":["PHD-2023-10682"]}],"id":[{"id":"10.13039\/501100018761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Military Medical Research"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.mmr.2026.100024","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:19:24Z","timestamp":1776417564000},"page":"100024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions"],"prefix":"10.1016","volume":"13","author":[{"given":"Sonu","family":"Rajput","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumeet Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poonam","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Weiskirchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umashanker","family":"Navik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mmr.2026.100024_bib1","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ymeth.2020.06.022","article-title":"Modern epigenetics methods in biological research","volume":"187","author":"Li","year":"2021","journal-title":"Methods"},{"issue":"11","key":"10.1016\/j.mmr.2026.100024_bib2","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/CS20120504","article-title":"Histone deacetylases as targets for treatment of multiple diseases","volume":"124","author":"Tang","year":"2013","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib3","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"7766","key":"10.1016\/j.mmr.2026.100024_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","article-title":"Advances in epigenetics link genetics to the environment and disease","volume":"571","author":"Cavalli","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mmr.2026.100024_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejim.2023.05.036","article-title":"How epigenetics impacts on human diseases","volume":"114","author":"Farsetti","year":"2023","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.mmr.2026.100024_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-981-15-3449-2_1","article-title":"Epigenetics in health and disease","volume":"1253","author":"Zhang","year":"2020","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib8","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41392-022-01300-8","article-title":"Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets","volume":"8","author":"Shu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.mmr.2026.100024_bib9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1749-6632.2003.tb05964.x","article-title":"Histone deacetylases: unique players in shaping the epigenetic histone code","volume":"983","author":"Thiagalingam","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4068\/cmj.2016.52.1.1","article-title":"HDAC and HDAC inhibitor: from cancer to cardiovascular diseases","volume":"52","author":"Yoon","year":"2016","journal-title":"Chonnam Med J"},{"issue":"8","key":"10.1016\/j.mmr.2026.100024_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5483\/BMBRep.2024-0122","article-title":"Contribution of histone deacetylases (HDACS) to the regulation of histone and non-histone proteins: implications for fibrotic diseases","volume":"58","author":"Jang","year":"2025","journal-title":"BMB reports"},{"issue":"11","key":"10.1016\/j.mmr.2026.100024_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016349","article-title":"Histone deacetylase inhibitors: a novel strategy for neuroprotection and cardioprotection following ischemia\/reperfusion injury","volume":"9","author":"Pickell","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib13","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.coph.2006.03.010","article-title":"Histone deacetylase inhibitors: gathering pace","volume":"6","author":"Carey","year":"2006","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.mmr.2026.100024_bib14","article-title":"Beyond histone and deacetylase: an overview of cytoplasmic histone deacetylases and their nonhistone substrates","volume":"2011","author":"Yao","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.mmr.2026.100024_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1216548","article-title":"Histone deacetylase 6's function in viral infection, innate immunity, and disease: latest advances","volume":"14","author":"Qu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.mmr.2026.100024_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105274","article-title":"HDAC6 as privileged target in drug discovery: a perspective","volume":"163","author":"Pulya","year":"2021","journal-title":"Pharmacol Res"},{"issue":"28","key":"10.1016\/j.mmr.2026.100024_bib17","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2174\/1568026619666181129141822","article-title":"Structure, functions and selective inhibitors of HDAC6","volume":"18","author":"Liang","year":"2018","journal-title":"Curr Top Med Chem"},{"issue":"6","key":"10.1016\/j.mmr.2026.100024_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.mmr.2026.100024_bib19","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bcp.2012.06.014","article-title":"Development and therapeutic impact of HDAC6-selective inhibitors","volume":"84","author":"Dallavalle","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mmr.2026.100024_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116996","article-title":"HDAC6 is involved in diabetic nephropathy by regulating TGF\u03b2\/SMADS and NF-\u03baB signaling pathways","volume":"239","author":"Li","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mmr.2026.100024_bib21","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2016.05.014","article-title":"Overexpression of HDAC6 induces pro-inflammatory responses by regulating ROS-MAPK-NF-\u03baB\/AP-1 signaling pathways in macrophages","volume":"97","author":"Youn","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mmr.2026.100024_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763831","article-title":"The role of HDAC6 in autophagy and NLRP3 inflammasome","volume":"12","author":"Chang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.mmr.2026.100024_bib23","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.taap.2019.03.017","article-title":"HDAC6 inhibition blocks inflammatory signaling and caspase-1 activation in LPS-induced acute lung injury","volume":"370","author":"Liu","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/TA.0000000000000510","article-title":"Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model","volume":"78","author":"Li","year":"2015","journal-title":"J Trauma Acute Care Surg"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib25","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1021\/acsmedchemlett.9b00560","article-title":"Structural and in vivo characterization of Tubastatin A, a widely used histone deacetylase 6 inhibitor","volume":"11","author":"Shen","year":"2020","journal-title":"ACS Med Chem Lett"},{"issue":"12","key":"10.1016\/j.mmr.2026.100024_bib26","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/cvr\/cvae144","article-title":"Genetic deletion or pharmacologic inhibition of histone deacetylase 6 protects the heart against ischaemia\/reperfusion injury by limiting tumour necrosis factor alpha-induced mitochondrial injury in experimental diabetes","volume":"120","author":"Baumgardt","year":"2024","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s42255-021-00515-3","article-title":"Histone deacetylase 6 inhibition restores leptin sensitivity and reduces obesity","volume":"4","author":"\u00c7ak\u0131r","year":"2022","journal-title":"Nat Metab"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/jlcr.3360","article-title":"Exploration of the labeling of [11C]Tubastatin A at the hydroxamic acid site with [11C]carbon monoxide","volume":"59","author":"Lu","year":"2016","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/j.mmr.2026.100024_bib29","article-title":"Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of \u03b1-tubulin acetylation and FGF-21 up-regulation","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"31","key":"10.1016\/j.mmr.2026.100024_bib30","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, Tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib31","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1021\/acs.jmedchem.0c01782","article-title":"A review of progress in histone deacetylase 6 inhibitors research: structural specificity and functional diversity","volume":"64","author":"Zhang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.mmr.2026.100024_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102677","article-title":"Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis","volume":"62","author":"Liu","year":"2023","journal-title":"Redox Biol"},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/onco.13673","article-title":"First-in-class selective HDAC6 inhibitor (ACY-1215) has a highly favorable safety profile in patients with relapsed and refractory lymphoma","volume":"26","author":"Amengual","year":"2021","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00262-023-03624-y","article-title":"HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapy","volume":"73","author":"Wen","year":"2024","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib35","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.18632\/oncotarget.13738","article-title":"Selective HDAC inhibition by ACY-241 enhances the activity of paclitaxel in solid tumor models","volume":"8","author":"Huang","year":"2017","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.mmr.2026.100024_bib36","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1158\/1078-0432.CCR-21-0238","article-title":"Preclinical development and first-in-human study of KA2507, a selective and potent inhibitor of histone deacetylase 6, for patients with refractory solid tumors","volume":"27","author":"Tsimberidou","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mmr.2026.100024_bib37","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.584664","article-title":"On the use of TMS to investigate the pathophysiology of neurodegenerative diseases","volume":"11","author":"Rawji","year":"2020","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib38","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10534-025-00665-x","article-title":"Heavy metal-induced disruption of the autophagy-lysosomal pathway: implications for aging and neurodegenerative disorders","volume":"38","author":"Das","year":"2025","journal-title":"BioMetals"},{"issue":"15","key":"10.1016\/j.mmr.2026.100024_bib39","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.3390\/ijms26157342","article-title":"Investigating neuroprotective effects of berberine on mitochondrial dysfunction and autophagy impairment in Parkinson\u2019s disease","volume":"26","author":"Cha","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"1-2","key":"10.1016\/j.mmr.2026.100024_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11010-010-0563-x","article-title":"Metals, oxidative stress and neurodegenerative disorders","volume":"345","author":"Jomova","year":"2010","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"10.1016\/j.mmr.2026.100024_bib41","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tcb.2008.04.003","article-title":"HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions","volume":"18","author":"Valenzuela-Fern\u00e1ndez","year":"2008","journal-title":"Trends Cell Biol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100024_bib42","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1128\/MCB.25.8.2873-2884.2005","article-title":"Class II histone deacetylases: from sequence to function, regulation, and clinical implication","volume":"25","author":"Yang","year":"2005","journal-title":"Mol Cell Biol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib43","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2217\/epi.14.69","article-title":"Histone deacetylase 6 in health and disease","volume":"7","author":"Seidel","year":"2015","journal-title":"Epigenomics"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib44","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.1038\/s41598-020-62678-5","article-title":"Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity","volume":"10","author":"Francelle","year":"2020","journal-title":"Sci Rep"},{"issue":"28","key":"10.1016\/j.mmr.2026.100024_bib45","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.0803749105","article-title":"HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation","volume":"105","author":"Parmigiani","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mmr.2026.100024_bib46","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2017.08.029","article-title":"Inhibition of HDAC6 increases acetylation of peroxiredoxin1\/2 and ameliorates 6-OHDA induced dopaminergic injury","volume":"658","author":"Jian","year":"2017","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mmr.2026.100024_bib47","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fnagi.2020.00078","article-title":"Pharmacological inhibition of HDAC6 attenuates NLRP3 inflammatory response and protects dopaminergic neurons in experimental models of Parkinson\u2019s disease","volume":"12","author":"Yan","year":"2020","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.mmr.2026.100024_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.105141","article-title":"HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy","volume":"149","author":"Du","year":"2021","journal-title":"Neurochem Int"},{"key":"10.1016\/j.mmr.2026.100024_bib49","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.phrs.2015.11.024","article-title":"Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: therapeutic implications for Parkinson\u2019s disease","volume":"103","author":"Pinho","year":"2016","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib50","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2014.05.134","article-title":"Involvement of transcription factor XBP1s in the resistance of HDAC6 inhibitor Tubastatin A to superoxidation via acetylation-mediated proteasomal degradation","volume":"450","author":"Zhang","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jphs.2020.06.007","article-title":"TLR4-TAK1-p38 MAPK pathway and HDAC6 regulate the expression of sigma-1 receptors in rat primary cultured microglia","volume":"144","author":"Iwamoto","year":"2020","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.mmr.2026.100024_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1515787","article-title":"Histone deacetylases: the critical enzymes for microglial activation involved in neuropathic pain","volume":"16","author":"Ding","year":"2025","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib53","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s13311-023-01393-1","article-title":"Axonal transport defect in gigaxonin deficiency rescued by Tubastatin A","volume":"20","author":"Nath","year":"2023","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.mmr.2026.100024_bib54","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.canlet.2017.01.025","article-title":"A novel HDAC6 inhibitor Tubastatin A: controls HDAC6-p97\/VCP-mediated ubiquitination-autophagy turnover and reverses temozolomide-induced er stress-tolerance in GBM cells","volume":"391","author":"Li","year":"2017","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","article-title":"The neuropathological diagnosis of Alzheimer\u2019s disease","volume":"14","author":"DeTure","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"6","key":"10.1016\/j.mmr.2026.100024_bib56","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41419-018-0688-5","article-title":"The novel histone deacetylase 6 inhibitor, MPT0G211, ameliorates tau phosphorylation and cognitive deficits in an Alzheimer\u2019s disease model","volume":"9","author":"Fan","year":"2018","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib57","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/alzrt241","article-title":"Histone deacetylase 6 inhibition improves memory and reduces total tau levels in a mouse model of tau deposition","volume":"6","author":"Selenica","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib58","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.bbrc.2012.11.034","article-title":"Brain expression level and activity of HDAC6 protein in neurodegenerative dementia","volume":"430","author":"Odagiri","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mmr.2026.100024_bib59","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1750-1326-8-7","article-title":"HDAC6 as a target for neurodegenerative diseases: what makes it different from the other HDACs?","volume":"8","author":"Sim\u00f5es-Pires","year":"2013","journal-title":"Mol Neurodegener"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib60","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.3233\/JAD-140066","article-title":"Tubastatin A\/ACY-1215 improves cognition in Alzheimer\u2019s disease transgenic mice","volume":"41","author":"Zhang","year":"2014","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib61","first-page":"3363","article-title":"Inhibition of HDAC6 expression decreases brain injury induced by APOE4 and A\u03b2 co\u2011aggregation in rats","volume":"20","author":"Ding","year":"2019","journal-title":"Mol Med Rep"},{"issue":"28","key":"10.1016\/j.mmr.2026.100024_bib62","doi-asserted-by":"crossref","first-page":"5105","DOI":"10.2174\/1381612811319280009","article-title":"Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery","volume":"19","author":"Fessler","year":"2013","journal-title":"Curr Pharm Des"},{"issue":"8","key":"10.1016\/j.mmr.2026.100024_bib63","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.3390\/antiox14081015","article-title":"Epigenetic regulation in ischemic neuroprotection: the dual role of HDACs and HATs in neuroinflammation and recovery","volume":"14","author":"Lisek","year":"2025","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.mmr.2026.100024_bib64","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nri3086","article-title":"Microglial cell origin and phenotypes in health and disease","volume":"11","author":"Saijo","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib65","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.suc.2017.06.008","article-title":"Trauma: Spinal cord injury","volume":"97","author":"Eckert","year":"2017","journal-title":"Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14439","article-title":"Inhibition of HDAC6 promotes microvascular endothelial cells to phagocytize myelin debris and reduces inflammatory response to accelerate the repair of spinal cord injury","volume":"30","author":"Wu","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.mmr.2026.100024_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.mtbio.2022.100454","article-title":"A bionic multichannel nanofiber conduit carrying Tubastatin A for repairing injured spinal cord","volume":"17","author":"Liao","year":"2022","journal-title":"Materials Today Bio"},{"issue":"8","key":"10.1016\/j.mmr.2026.100024_bib68","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/biomedicines10081938","article-title":"Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease","volume":"10","author":"Fr\u0105k","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.mmr.2026.100024_bib69","article-title":"Vascular age: a narrative review of assessment methods, clinical applications, and future directions","volume":"29","author":"Yang","year":"2026","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"issue":"17","key":"10.1016\/j.mmr.2026.100024_bib70","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/CIRCULATIONAHA.114.008720","article-title":"Global and regional patterns in cardiovascular mortality from 1990 to 2013","volume":"132","author":"Roth","year":"2015","journal-title":"Circulation"},{"issue":"37","key":"10.1016\/j.mmr.2026.100024_bib71","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/sj.onc.1210614","article-title":"HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination","volume":"26","author":"Boyault","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.mmr.2026.100024_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/641979","article-title":"Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases","volume":"2014","author":"Wang","year":"2014","journal-title":"Oxid Med Cell Longev"},{"issue":"10","key":"10.1016\/j.mmr.2026.100024_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165836","article-title":"Acetylation in cardiovascular diseases: molecular mechanisms and clinical implications","volume":"1866","author":"Yang","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib74","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024205","article-title":"Tubastatin A improves post-resuscitation myocardial dysfunction by inhibiting NLRP3-mediated pyroptosis through enhancing transcription factor EB signaling","volume":"11","author":"Xu","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.mmr.2026.100024_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104281","article-title":"Histone deacetylase 6 inhibitor Tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine \u03b3-lyase protein degradation","volume":"146","author":"Chi","year":"2019","journal-title":"Pharmacol Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib76","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1038\/s41598-017-04874-4","article-title":"HDAC6: a novel histone deacetylase implicated in pulmonary arterial hypertension","volume":"7","author":"Boucherat","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.mmr.2026.100024_bib77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yjmcc.2018.10.007","article-title":"HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving \u03b1-tubulin acetylation","volume":"124","author":"Song","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.mmr.2026.100024_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9494052","article-title":"Inhibition of HDAC6 activity alleviates myocardial ischemia\/reperfusion injury in diabetic rats: potential role of peroxiredoxin 1 acetylation and redox regulation","volume":"2018","author":"Leng","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"10.1016\/j.mmr.2026.100024_bib79","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.amjhyper.2004.02.004","article-title":"Reactive oxygen species in hypertension; an update","volume":"17","author":"Lass\u00e8gue","year":"2004","journal-title":"Am J Hypertens"},{"issue":"10","key":"10.1016\/j.mmr.2026.100024_bib80","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1161\/HYPERTENSIONAHA.121.18935","article-title":"Telomere shortening in hypertensive heart disease depends on oxidative DNA damage and predicts impaired recovery of cardiac function in heart failure","volume":"79","author":"Brandt","year":"2022","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib81","doi-asserted-by":"crossref","first-page":"E392","DOI":"10.1152\/ajpendo.00398.2012","article-title":"NOX2 deficiency attenuates markers of adiposopathy and brain injury induced by high-fat diet","volume":"304","author":"Pepping","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.mmr.2026.100024_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1072513","article-title":"Preoperative circulating peroxiredoxin 1 levels as a predictor of non-alcoholic fatty liver disease remission after laparoscopic bariatric surgery","volume":"13","author":"Cheng","year":"2022","journal-title":"Front Endocrinol"},{"issue":"10","key":"10.1016\/j.mmr.2026.100024_bib83","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/ars.2018.7674","article-title":"The role of NADPH oxidases in the etiology of obesity and metabolic syndrome: contribution of individual isoforms and cell biology","volume":"31","author":"DeVallance","year":"2019","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mmr.2026.100024_bib84","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.freeradbiomed.2017.05.008","article-title":"Aging-associated metabolic disorder induces Nox2 activation and oxidative damage of endothelial function","volume":"108","author":"Fan Lampson","year":"2017","journal-title":"Free Radic Biol Med"},{"issue":"16","key":"10.1016\/j.mmr.2026.100024_bib85","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1177\/15353702211005390","article-title":"Cancer and stem cells","volume":"246","author":"Yin","year":"2021","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/j.mmr.2026.100024_bib86","unstructured":"Cancer: World Health Organization (WHO); 2025. \u3008https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer\u3009. Accessed 3 Mar, 2026."},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib87","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"10.1016\/j.mmr.2026.100024_bib88","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nrc3130","article-title":"A decade of exploring the cancer epigenome - biological and translational implications","volume":"11","author":"Baylin","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib90","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2174\/1568026615666150825141330","article-title":"Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments","volume":"16","author":"Schnekenburger","year":"2016","journal-title":"Curr Top Med Chem"},{"issue":"1-2","key":"10.1016\/j.mmr.2026.100024_bib91","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mrrev.2008.02.004","article-title":"Epigenetic interplay between histone modifications and DNA methylation in gene silencing","volume":"659","author":"Vaissi\u00e8re","year":"2008","journal-title":"Mutat Res"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib92","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s12672-026-04391-9","article-title":"Role of HDAC6 in carcinomas","volume":"17","author":"Chen","year":"2026","journal-title":"Discov Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100024_bib93","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.molonc.2012.07.003","article-title":"Histone deacetylases and cancer","volume":"6","author":"Barneda-Zahonero","year":"2012","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib94","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/pharmaceutics16010054","article-title":"Role of histone deacetylase 6 and histone deacetylase 6 inhibition in colorectal cancer","volume":"16","author":"Vuleti\u0107","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.mmr.2026.100024_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108932","article-title":"Histone deacetylase 6: a potential therapeutic target for drug development","volume":"165","author":"Li","year":"2025","journal-title":"Bioorg Chem"},{"issue":"15","key":"10.1016\/j.mmr.2026.100024_bib96","doi-asserted-by":"crossref","first-page":"11219","DOI":"10.1074\/jbc.M109.042754","article-title":"The microtubule-associated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation","volume":"285","author":"Gao","year":"2010","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib97","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12929-023-00898-3","article-title":"Inhibition of histone deacetylase 6 destabilizes ERK phosphorylation and suppresses cancer proliferation via modulation of the tubulin acetylation-GRP78 interaction","volume":"30","author":"Wattanathamsan","year":"2023","journal-title":"J Biomed Sci"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib98","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s13402-022-00704-6","article-title":"HDAC6: a unique HDAC family member as a cancer target","volume":"45","author":"Kaur","year":"2022","journal-title":"Cell Oncol"},{"key":"10.1016\/j.mmr.2026.100024_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1164514","article-title":"Inhibition of histone deacetylases attenuates tumor progression and improves immunotherapy in breast cancer","volume":"14","author":"Lian","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib100","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib101","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40164-025-00737-1","article-title":"Epigenetic and post-translational regulatory networks of ferroptosis in the tumor immune microenvironment","volume":"15","author":"Du","year":"2026","journal-title":"Exp Hematol Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib102","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"10.1016\/j.mmr.2026.100024_bib103","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib104","doi-asserted-by":"crossref","first-page":"599","DOI":"10.3390\/antiox9070599","article-title":"Inhibition of HDAC6 attenuates diabetes-induced retinal redox imbalance and microangiopathy","volume":"9","author":"Abouhish","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib105","first-page":"63","article-title":"Epidemiology of melanoma","volume":"9","author":"Saginala","year":"2021","journal-title":"Med Sci (Basel)"},{"issue":"11","key":"10.1016\/j.mmr.2026.100024_bib106","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.3390\/medicina61111941","article-title":"Severe sunburns and sunbed use risk with cutaneous melanoma: a case-control study in Lithuania","volume":"61","author":"Butrimas","year":"2025","journal-title":"Medicina (Kaunas)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib107","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1158\/1055-9965.EPI-14-0650","article-title":"Sun protection practices and sun exposure among children with a parental history of melanoma","volume":"24","author":"Glenn","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.mmr.2026.100024_bib108","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/598571","article-title":"Nonsteroidal anti-inflammatory drugs and risk of melanoma","volume":"2011","author":"Jeter","year":"2011","journal-title":"J Skin Cancer"},{"issue":"11","key":"10.1016\/j.mmr.2026.100024_bib109","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/1940-6207.CAPR-22-0229","article-title":"Use of nonsteroidal anti-inflammatory drugs and incidence of melanoma in the united states radiologic technologists study","volume":"15","author":"Mai","year":"2022","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.12492","article-title":"Emerging trends in the epidemiology of melanoma","volume":"170","author":"Nikolaou","year":"2014","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib111","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.molonc.2015.04.002","article-title":"Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: enhanced antitumor immunity and impaired cell proliferation","volume":"9","author":"Woan","year":"2015","journal-title":"Mol Oncol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib112","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1002\/cncr.24899","article-title":"Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant melanoma","volume":"116","author":"Hino","year":"2010","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.mmr.2026.100024_bib113","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s00262-006-0164-4","article-title":"Epigenetic regulation of immune escape genes in cancer","volume":"55","author":"Tomasi","year":"2006","journal-title":"Cancer Immunol Immunother"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib114","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.molonc.2015.12.012","article-title":"Essential role of HDAC6 in the regulation of PD-L1 in melanoma","volume":"10","author":"Lienlaf","year":"2016","journal-title":"Mol Oncol"},{"key":"10.1016\/j.mmr.2026.100024_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155174","article-title":"Beyond genetics: exploring the role of epigenetic alterations in breast cancer","volume":"254","author":"Prabhu","year":"2024","journal-title":"Pathol Res Pract"},{"issue":"45","key":"10.1016\/j.mmr.2026.100024_bib116","doi-asserted-by":"crossref","first-page":"5952","DOI":"10.1038\/s41388-018-0379-9","article-title":"Histone deacetylase 6 regulates the immunosuppressive properties of cancer-associated fibroblasts in breast cancer through the STAT3-COX2-dependent pathway","volume":"37","author":"Li","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.mmr.2026.100024_bib117","article-title":"The role of HDAC6 in cancer","volume":"2011","author":"Aldana-Masangkay","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.mmr.2026.100024_bib118","doi-asserted-by":"crossref","first-page":"6503","DOI":"10.2147\/IJN.S136142","article-title":"Combination of palladium nanoparticles and tubastatin-A potentiates apoptosis in human breast cancer cells: a novel therapeutic approach for cancer","volume":"12","author":"Yuan","year":"2017","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"10.1016\/j.mmr.2026.100024_bib119","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/mco.2013.172","article-title":"Glioma and glioblastoma - how much do we (not) know?","volume":"1","author":"Jov\u010devska","year":"2013","journal-title":"Mol Clin Oncol"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib120","first-page":"1797","article-title":"Tubastatin A, an inhibitor of HDAC6, enhances temozolomide\u2011induced apoptosis and reverses the malignant phenotype of glioblastoma cells","volume":"54","author":"Urdiciain","year":"2019","journal-title":"Int J Oncol"},{"issue":"6","key":"10.1016\/j.mmr.2026.100024_bib121","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.3390\/ijms24065771","article-title":"Combined inhibition of hedgehog and HDAC6: in vitro and in vivo studies reveal a new role for lysosomal stress in reducing glioblastoma cell viability","volume":"24","author":"Pezzotta","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib122","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.3892\/or.2017.5981","article-title":"Synergistic antitumor effects of the combined treatment with an HDAC6 inhibitor and a COX-2 inhibitor through activation of PTEN","volume":"38","author":"Zhang","year":"2017","journal-title":"Oncol Rep"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib123","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1158\/1541-7786.MCR-13-0654","article-title":"NEDD9 regulates actin dynamics through cortactin deacetylation in an AURKA\/HDAC6-dependent manner","volume":"12","author":"Kozyreva","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.mmr.2026.100024_bib124","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3389\/fgene.2018.00361","article-title":"Epigenetics and metabolism in health and disease","volume":"9","author":"Tzika","year":"2018","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib125","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.tem.2016.02.001","article-title":"Metabolically healthy obesity: personalised and public health implications","volume":"27","author":"Phillips","year":"2016","journal-title":"Trends Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib126","article-title":"Epigenetic mechanisms in the transfer of metabolic disorders: a comprehensive review","volume":"17","author":"Nl","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib127","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41392-023-01333-7","article-title":"Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study","volume":"8","author":"Wu","year":"2023","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"10.1016\/j.mmr.2026.100024_bib128","doi-asserted-by":"crossref","first-page":"E1255","DOI":"10.1210\/JC.2015-2284","article-title":"Acute sleep loss induces tissue-specific epigenetic and transcriptional alterations to circadian clock genes in men","volume":"100","author":"Cedernaes","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib129","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1210\/jc.2015-3924","article-title":"Effects of the internal circadian system and circadian misalignment on glucose tolerance in chronic shift workers","volume":"101","author":"Morris","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1748-1716.2011.02278.x","article-title":"Diet induced epigenetic changes and their implications for health","volume":"202","author":"McKay","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"issue":"12","key":"10.1016\/j.mmr.2026.100024_bib131","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/genes15121599","article-title":"Epigenetic mechanisms in aging: extrinsic factors and gut microbiome","volume":"15","author":"Borrego-Ruiz","year":"2024","journal-title":"Genes"},{"key":"10.1016\/j.mmr.2026.100024_bib132","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13148-015-0101-5","article-title":"Recent developments on the role of epigenetics in obesity and metabolic disease","volume":"7","author":"van Dijk","year":"2015","journal-title":"Clin Epigenetics"},{"issue":"8","key":"10.1016\/j.mmr.2026.100024_bib133","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tibs.2016.05.008","article-title":"The metabolic impact on histone acetylation and transcription in ageing","volume":"41","author":"Peleg","year":"2016","journal-title":"Trends Biochem Sci"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib134","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/17460441.2021.1877656","article-title":"An update on the emerging approaches for histone deacetylase (HDAC) inhibitor drug discovery and future perspectives","volume":"16","author":"Su","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"10.1016\/j.mmr.2026.100024_bib135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109166","article-title":"Inhibition of HDAC6 attenuates LPS-induced inflammation in macrophages by regulating oxidative stress and suppressing the TLR4-MAPK\/NF-\u03baB pathways","volume":"117","author":"Zhang","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.mmr.2026.100024_bib136","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.biopha.2017.10.103","article-title":"Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK\/NF-\u03baB pathway","volume":"97","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib137","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jcmgh.2020.10.006","article-title":"S100A11 promotes liver steatosis via FOXO1-mediated autophagy and lipogenesis","volume":"11","author":"Zhang","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.mmr.2026.100024_bib138","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrendo.2016.107","article-title":"The pathophysiology of defective proteostasis in the hypothalamus \u2013 from obesity to ageing","volume":"12","author":"Cavadas","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib139","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1038\/s41467-022-34831-3","article-title":"Pharmacological inhibition of HDAC6 improves muscle phenotypes in dystrophin-deficient mice by downregulating TGF-\u03b2 via Smad3 acetylation","volume":"13","author":"Osseni","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib140","doi-asserted-by":"crossref","DOI":"10.1111\/apha.14243","article-title":"Histone deacetylase 6 inhibition promotes microtubule acetylation and facilitates autophagosome-lysosome fusion in dystrophin-deficient mdx mice","volume":"241","author":"Agrawal","year":"2025","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.mmr.2026.100024_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106856","article-title":"ROS-responsive thioketal nanoparticles delivering system for targeted ulcerative colitis therapy with potent HDAC6 inhibitor, Tubastatin A","volume":"201","author":"Shrestha","year":"2024","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib142","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1038\/s41598-024-80903-3","article-title":"Clusterin inhibits lipopolysaccharide induced liver injury","volume":"15","author":"Seo","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.mmr.2026.100024_bib143","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.intimp.2018.01.039","article-title":"Inhibition of histone deacetylase reduces lipopolysaccharide-induced-inflammation in primary mammary epithelial cells by regulating ROS-NF-\u043aB signaling pathways","volume":"56","author":"Wang","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"4","key":"10.1016\/j.mmr.2026.100024_bib144","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/HEP.0000000000001055","article-title":"Cholangiocyte ciliary defects induce sustained epidermal growth factor receptor signaling","volume":"81","author":"Pant","year":"2025","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib145","doi-asserted-by":"crossref","first-page":"50","DOI":"10.14740\/gr1584","article-title":"Ischemic reperfusion injury after liver transplantation: is there a place for conservative management?","volume":"16","author":"Obed","year":"2023","journal-title":"Gastroenterology Res"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib146","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/ajt.16219","article-title":"Ischemia-reperfusion injury and its relationship with early allograft dysfunction in liver transplant patients","volume":"21","author":"Ito","year":"2021","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.mmr.2026.100024_bib147","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1097\/TP.0000000000005042","article-title":"Differential effects of HDAC6 inhibition versus knockout during hepatic ischemia-reperfusion injury highlight importance of HDAC6 C-terminal zinc-finger ubiquitin-binding domain","volume":"108","author":"Concors","year":"2024","journal-title":"Transplantation"},{"issue":"27","key":"10.1016\/j.mmr.2026.100024_bib148","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2174\/1381612825666190709205421","article-title":"Update on autoimmune diseases pathogenesis","volume":"25","author":"Kechida","year":"2019","journal-title":"Curr Pharm Des"},{"issue":"7539","key":"10.1016\/j.mmr.2026.100024_bib149","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13835","article-title":"Genetic and epigenetic fine mapping of causal autoimmune disease variants","volume":"518","author":"Farh","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.mmr.2026.100024_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1482728","article-title":"Autoimmune disease: a view of epigenetics and therapeutic targeting","volume":"15","author":"Mu","year":"2024","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib151","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13075-017-1357-2","article-title":"Therapeutic effect of a novel histone deacetylase 6 inhibitor, CKD-L, on collagen-induced arthritis in vivo and regulatory T cells in rheumatoid arthritis in vitro","volume":"19","author":"Oh","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib152","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.taap.2013.04.014","article-title":"Largazole, a class I histone deacetylase inhibitor, enhances TNF-\u03b1-induced ICAM-1 and VCAM-1 expression in rheumatoid arthritis synovial fibroblasts","volume":"270","author":"Ahmed","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib153","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.intimp.2013.03.016","article-title":"Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects","volume":"16","author":"Vishwakarma","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.mmr.2026.100024_bib154","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.nutos.2025.02.002","article-title":"Dietary fibre intervention in Hashimoto's thyroiditis patients and its impact on the gut microbiota","volume":"60","author":"Jiayin","year":"2025","journal-title":"Clin Nutr Open Sci"},{"key":"10.1016\/j.mmr.2026.100024_bib155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.molimm.2022.05.004","article-title":"HDAC6-specific inhibitor alleviates hashimoto's thyroiditis through inhibition of Th17 cell differentiation","volume":"149","author":"Chang","year":"2022","journal-title":"Mol Immunol"},{"key":"10.1016\/j.mmr.2026.100024_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108360","article-title":"Discovery of novel selective HDAC6 inhibitors via a scaffold hopping approach for the treatment of idiopathic pulmonary fibrosis (IPF) in vitro and in vivo","volume":"159","author":"Quan","year":"2025","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.mmr.2026.100024_bib157","series-title":"Targeting epigenetics in inflammatory lung diseases","first-page":"145","article-title":"Epigenetics of idiopathic pulmonary fibrosis","author":"Singh","year":"2023"},{"issue":"10","key":"10.1016\/j.mmr.2026.100024_bib158","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186615","article-title":"Tubastatin ameliorates pulmonary fibrosis by targeting the TGF\u03b2-PI3K-Akt pathway","volume":"12","author":"Saito","year":"2017","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.mmr.2026.100024_bib159","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/jpp\/rgab106","article-title":"Tubastatin A suppresses the proliferation of fibroblasts in epidural fibrosis through phosphatidylinositol-3-kinase\/protein kinase B\/mammalian target of rapamycin (PI3K\/Akt\/mTOR) signalling pathway","volume":"74","author":"Liu","year":"2022","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1016\/j.mmr.2026.100024_bib160","doi-asserted-by":"crossref","first-page":"56","DOI":"10.5603\/FHC.a2023.0006","article-title":"HDAC6 inhibition alleviates acute pulmonary embolism: a possible future therapeutic option","volume":"61","author":"Zhou","year":"2023","journal-title":"Folia Histochem Cytobiol"},{"key":"10.1016\/j.mmr.2026.100024_bib161","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1007\/s10753-018-0853-0","article-title":"Protective effect of Tubastatin A in CLP-induced lethal sepsis","volume":"41","author":"Deng","year":"2018","journal-title":"Inflammation"},{"issue":"14","key":"10.1016\/j.mmr.2026.100024_bib162","doi-asserted-by":"crossref","first-page":"6724","DOI":"10.3390\/ijms26146724","article-title":"Oxidative stress in HIV-associated neurodegeneration: mechanisms of pathogenesis and therapeutic targets","volume":"26","author":"Gagliardi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mmr.2026.100024_bib163","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.redox.2017.05.001","article-title":"Crosstalk between HDAC6 and Nox2-based NADPH oxidase mediates HIV-1 Tat-induced pro-inflammatory responses in astrocytes","volume":"12","author":"Youn","year":"2017","journal-title":"Redox Biol"},{"issue":"7","key":"10.1016\/j.mmr.2026.100024_bib164","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1134\/S0006297914070050","article-title":"Selective inhibitor of histone deacetylase 6 (Tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes","volume":"79","author":"Kozlov","year":"2014","journal-title":"Biochemistry (Mosc"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1507\/endocrj.EJ12-0299","article-title":"Evaluation of the diagnostic criteria for Cushing's disease in Japan","volume":"60","author":"Kageyama","year":"2013","journal-title":"Endocr J"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib166","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1210\/en.2005-0544","article-title":"Inhibition of 11\u03b2-hydroxysteroid dehydrogenase eliminates impaired glucocorticoid suppression and induces apoptosis in corticotroph tumor cells","volume":"147","author":"Nigawara","year":"2006","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.mmr.2026.100024_bib167","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1507\/endocrj.EJ21-0778","article-title":"Effects of Tubastatin A on adrenocorticotropic hormone synthesis and proliferation of AtT-20 corticotroph tumor cells","volume":"69","author":"Hagiwara","year":"2022","journal-title":"Endoc J"},{"issue":"8","key":"10.1016\/j.mmr.2026.100024_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.415","article-title":"HDAC6 inhibition by Tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness","volume":"8","author":"Leyk","year":"2017","journal-title":"Cell Death Dis"},{"issue":"2","key":"10.1016\/j.mmr.2026.100024_bib169","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/17460441.2018.1417380","article-title":"Phenotypic screening approaches for Chagas disease drug discovery","volume":"13","author":"Chatelain","year":"2018","journal-title":"Expert Opin Drug Discov"},{"issue":"5","key":"10.1016\/j.mmr.2026.100024_bib170","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.chom.2016.04.020","article-title":"Epigenetic regulation of virulence gene expression in parasitic protozoa","volume":"19","author":"Duraisingh","year":"2016","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mmr.2026.100024_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejop.2021.125821","article-title":"Tubastatin A, a deacetylase inhibitor, as a tool to study the division, cell cycle and microtubule cytoskeleton of trypanosomatids","volume":"80","author":"de Oliveira Santos","year":"2021","journal-title":"Eur J Protistol"},{"issue":"8","key":"10.1016\/j.mmr.2026.100024_bib172","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1593\/neo.11558","article-title":"HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma","volume":"13","author":"Subramanian","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.mmr.2026.100024_bib173","article-title":"Histone deacetylases and their inhibitors in inflammatory diseases","volume":"179","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother"},{"issue":"14","key":"10.1016\/j.mmr.2026.100024_bib174","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.3390\/cancers13143575","article-title":"HDAC inhibitors: dissecting mechanisms of action to counter tumor heterogeneity","volume":"13","author":"Karagiannis","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"17","key":"10.1016\/j.mmr.2026.100024_bib175","doi-asserted-by":"crossref","first-page":"17279","DOI":"10.1021\/acsomega.9b01950","article-title":"Crafting carbazole-based vorinostat and tubastatin-A-like histone deacetylase (HDAC) inhibitors with potent in vitro and in vivo neuroactive functions","volume":"4","author":"Reddy","year":"2019","journal-title":"ACS Omega"}],"container-title":["Military Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2054936926000282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:44:42Z","timestamp":1783161882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2054936926000282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":175,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2054936926000282"],"URL":"https:\/\/doi.org\/10.1016\/j.mmr.2026.100024","relation":{},"ISSN":["2054-9369"],"issn-type":[{"value":"2054-9369","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potential of HDAC6 inhibitor Tubastatin A in health and diseases: current perspective and future directions","name":"articletitle","label":"Article Title"},{"value":"Military Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mmr.2026.100024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of Military Science Publishing House.","name":"copyright","label":"Copyright"}],"article-number":"100024"}}